BAJAJ BROKING

Notification close image
No new Notification messages
card image
Amanta Healthcare Ltd IPO
Apply for the Amanta Healthcare Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

542918

GIANLIFE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Gian Life Care Limited Share Price Update

As of the latest trading session, Gian Life Care Limited share price is currently at ₹ 14, which is down by ₹ -0.54 from its previous closing. Today, the stock has fluctuated between ₹ 13.85 and ₹ 15.24. Over the past year, Gian Life Care Limited has achieved a return of -32.27 %. In the last month alone, the return has been -6.85 %. Read More...

Investment Returns

Over 1 Month -6.85% Over 3 Months -6.19% Over 6 Months 7.22% Over 1 Year -32.27%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Gian Life Care Limited fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    14.50

  • P/E Ratio (TTM)

    5.31

  • Beta

    0.44

  • Book Value / share

    19.21

  • Return on equity

    24.63%

  • EPS (TTM)

    2.74

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.38

info icon alternate text

Gian Life Care Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 1.59
Operating Expense 1.33
Net Profit 0.38
Net Profit Margin (%) 23.89
Earnings Per Share (EPS) 0.37
EBITDA 0.64
Effective Tax Rate (%) 9.52
Particulars SEP 2024 (Values in Cr)
Revenue 1.95
Operating Expense 1.94
Net Profit 0.14
Net Profit Margin (%) 7.17
Earnings Per Share (EPS) 0.14
EBITDA 0.39
Effective Tax Rate (%) 17.64
Particulars JUN 2024 (Values in Cr)
Revenue 1.98
Operating Expense 1.99
Net Profit 0.11
Net Profit Margin (%) 5.55
Earnings Per Share (EPS) 0.10
EBITDA 0.40
Effective Tax Rate (%) 35.29
Particulars MAR 2024 (Values in Cr)
Revenue 4.60
Operating Expense 1.68
Net Profit 2.20
Net Profit Margin (%) 47.82
Earnings Per Share (EPS) 2.13
EBITDA 3.28
Effective Tax Rate (%) 29.26
Particulars DEC 2023 (Values in Cr)
Revenue 3.79
Operating Expense 1.79
Net Profit 1.63
Net Profit Margin (%) 43.00
Earnings Per Share (EPS) 1.57
EBITDA 2.40
Effective Tax Rate (%) 24.53
Particulars MAR 2024 (Values in Cr)
Revenue 13.12
Operating Expense 7.85
Net Profit 4.30
Net Profit Margin (%) 32.77
Earnings Per Share (EPS) 4.16
EBITDA 6.82
Effective Tax Rate (%) 27.41
Particulars MAR 2023 (Values in Cr)
Revenue 11.92
Operating Expense 10.84
Net Profit 1.26
Net Profit Margin (%) 10.57
Earnings Per Share (EPS) 1.22
EBITDA 2.72
Effective Tax Rate (%) 29.60
Particulars MAR 2022 (Values in Cr)
Revenue 15.93
Operating Expense 10.58
Net Profit 4.37
Net Profit Margin (%) 27.43
Earnings Per Share (EPS) 4.23
EBITDA 6.52
Effective Tax Rate (%) 25.29
Particulars MAR 2021 (Values in Cr)
Revenue 10.46
Operating Expense 7.99
Net Profit 2.02
Net Profit Margin (%) 19.31
Earnings Per Share (EPS) 4.29
EBITDA 3.34
Effective Tax Rate (%) 26.90
Particulars MAR 2020 (Values in Cr)
Revenue 7.65
Operating Expense 6.18
Net Profit 1.13
Net Profit Margin (%) 14.77
Earnings Per Share (EPS) 3.13
EBITDA 2.12
Effective Tax Rate (%) 27.56
Particulars MAR 2024 (Values in Cr)
Book Value / Share 18.64
ROE % 24.13
ROCE % 27.80
Total Debt to Total Equity 0.27
EBITDA Margin 51.98
Particulars MAR 2023 (Values in Cr)
Book Value / Share 14.62
ROE % 7.27
ROCE % 11.22
Total Debt to Total Equity 0.23
EBITDA Margin 21.31
Particulars MAR 2022 (Values in Cr)
Book Value / Share 13.56
ROE % 31.15
ROCE % 38.66
Total Debt to Total Equity 0.14
EBITDA Margin 41.24
Particulars MAR 2024 (Values in Cr)
Book Value / Share 18.97
ROE % 24.63
ROCE % 28.36
Total Debt to Total Equity 0.25
EBITDA Margin 52.13
Particulars MAR 2023 (Values in Cr)
Book Value / Share 14.81
ROE % 8.59
ROCE % 12.25
Total Debt to Total Equity 0.23
EBITDA Margin 22.90
Particulars MAR 2022 (Values in Cr)
Book Value / Share 13.57
ROE % 36.89
ROCE % 46.55
Total Debt to Total Equity 0.13
EBITDA Margin 41.24
Particulars MAR 2021 (Values in Cr)
Book Value / Share 20.54
ROE % 23.35
ROCE % 32.06
Total Debt to Total Equity 0.12
EBITDA Margin 32.41
Particulars MAR 2020 (Values in Cr)
Book Value / Share 16.25
ROE % 29.16
ROCE % 37.88
Total Debt to Total Equity 0.31
EBITDA Margin 28.50
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.98
Total Assets 32.63
Total Liabilities 32.63
Total Equity 19.27
Share Outstanding 10341524
Price to Book Ratio 1.29
Return on Assets (%) 12.72
Return on Capital (%) 17.19
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 5.76
Total Assets 28.24
Total Liabilities 28.24
Total Equity 15.11
Share Outstanding 10341524
Price to Book Ratio 1.15
Return on Assets (%) 3.76
Return on Capital (%) 5.4
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.85
Total Assets 23.06
Total Liabilities 23.06
Total Equity 14.02
Share Outstanding 10341524
Price to Book Ratio 3.06
Return on Assets (%) 18.95
Return on Capital (%) 27.5
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.97
Total Assets 32.07
Total Liabilities 32.07
Total Equity 19.61
Share Outstanding 10341524
Price to Book Ratio 1.29
Return on Assets (%) 13.39
Return on Capital (%) 18.06
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 5.75
Total Assets 28.40
Total Liabilities 28.40
Total Equity 15.31
Share Outstanding 10341524
Price to Book Ratio 1.15
Return on Assets (%) 4.42
Return on Capital (%) 6.32
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.74
Total Assets 23.05
Total Liabilities 23.05
Total Equity 14.03
Share Outstanding 10341524
Price to Book Ratio 3.06
Return on Assets (%) 18.97
Return on Capital (%) 27.51
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.51
Total Assets 15.47
Total Liabilities 15.47
Total Equity 9.65
Share Outstanding 4700694
Price to Book Ratio 0.66
Return on Assets (%) 13.03
Return on Capital (%) 19.53
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.12
Total Assets 12.37
Total Liabilities 12.37
Total Equity 7.63
Share Outstanding 4700694
Price to Book Ratio 0.81
Return on Assets (%) 9.10
Return on Capital (%) 13.37
Particulars MAR 2024 (Values in Cr)
Net Income 5.74
Cash from Operations 0.71
Cash from Investing -0.31
Cash from Financing -0.16
Net change in Cash 0.22
Free Cash Flow 1.69
Particulars MAR 2023 (Values in Cr)
Net Income 1.59
Cash from Operations 2.24
Cash from Investing -0.94
Cash from Financing -0.36
Net change in Cash 0.91
Free Cash Flow 3.87
Particulars MAR 2022 (Values in Cr)
Net Income 5.84
Cash from Operations 6.46
Cash from Investing -4.12
Cash from Financing 0.67
Net change in Cash 2.34
Free Cash Flow 7.42
Particulars MAR 2024 (Values in Cr)
Net Income 5.91
Cash from Operations 0.76
Cash from Investing 0.32
Cash from Financing -0.85
Net change in Cash 0.22
Free Cash Flow 1.07
Particulars MAR 2023 (Values in Cr)
Net Income 1.78
Cash from Operations 2.33
Cash from Investing -0.94
Cash from Financing -0.36
Net change in Cash 1.00
Free Cash Flow 3.97
Particulars MAR 2022 (Values in Cr)
Net Income 5.85
Cash from Operations 6.46
Cash from Investing -4.23
Cash from Financing 0.67
Net change in Cash 2.23
Free Cash Flow 7.42
Particulars MAR 2021 (Values in Cr)
Net Income 2.75
Cash from Operations 3.16
Cash from Investing -1.09
Cash from Financing -0.38
Net change in Cash 1.38
Free Cash Flow 3.59
Particulars MAR 2020 (Values in Cr)
Net Income 1.55
Cash from Operations 1.73
Cash from Investing -3.96
Cash from Financing 2.55
Net change in Cash 0.09
Free Cash Flow 1.91
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7676.95 70.15 13.45 110382.76 6002.15 / 7981.20
FORTIS MALAR HOSPITALS LIMITED 67.36 27.38 4.18 126.24 51.01 / 98.70
SHREE PACETRONIX LTD. 167.30 57.69 4.36 60.22 61.11 / 187.00
TRANSGENE BIOTEK LTD. 3.99 0.00 3.01 30.23 3.22 / 8.88
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7676.95 81.68 12.63 110382.76 6002.15 / 7981.20
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 37.98 0.00 -15.01 28.37 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 6299.05 31.26 6.34 6891.16 4777.15 / 6525.00

Gian Life Care Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
14.00 -3.71 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 14.70
  • 26 Days 15.30
  • 10 Days 14.90
  • 50 Days 15.40
  • 12 Days 15.00
  • 100 Days 15.80
  • 20 Days 15.20
  • 200 Days 16.90
14.67 PIVOT

First Support

14.01

First Resistance

15.20

Second Support

13.48

Second Resistance

15.86

Third Support

12.82

Third Resistance

16.39

RSI

41.53

ADX

17.51

MACD

-0.30

Williams % R

-75.06

Commodity Channel Index (CCI)

-70.14

Date

2025-09-01

Week

18842.00

Same Day

31233.00

Month

18599.00

1 Year

0.45

3 Year

0.41

Over 1 Month

-6.85%

down

Over 1 Year

-32.27%

down

Over 3 Months

-6.19%

down

Over 3 Years

-23.90%

down

Over 6 Months

7.22%

down

Over 5 Years

5.56%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

Gian Life Care Limited shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

Gian Life Care Limited corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
30 Mar 2022 29 Mar 2022 6:5
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Gian Life Care Limited Share Price

Gian Life Care Limited was incorporated as a Public Limited Company and registered with the Registrar of Companies, Uttar Pradesh, Kanpur with the name & style 'Gian Life Care Limited' pursuant to a Certificate of Incorporation dated November 06, 2018. Subsequently, Company acquired the entire business of M/s Gian Pathology & X-Ray, sole proprietorship concern of its Promoter Mr. Arun Kumar Gupta w.e.f. March 01, 2019.

The diagnostic center under the name of 'M/s. Gian Pathology and X-Rays' was first established in Kanpur in year 1995 by Mr. Arun Kumar Gupta (MD Pathology) which has been taken-over by the Company. Mr. Arun Kumar Gupta completed his degree in Pathology from G.S.V.M. Medical College in Kanpur. Under his guidance and efforts the laboratory has taken the shape of a big diagnostic center which has its 2 branches across Kanpur and collection centers in its adjoining districts.

The Company is engaged in the business of providing diagnostic and related healthcare tests and services in Kanpur and nearby areas. It provides a broad range of diagnostic and related healthcare tests and services such as patient diagnosis, prevention and wellness diagnosis services to its patients and healthcare providers. The customers include individual patients, hospitals, other healthcare providers and corporate customers.

Apart from this, the Company offers a broad range of approximately 1,344 tests, it includes various tests ranging from biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, histopathology, immunoassay, microbiology, molecular biology and radiology services. It also designed certain test which includes a variety of test combinations which are specific to some disease or disorder or wellness that are used for health and fitness screening.

In January 2020, the Company raised money from public through IPO by issuing 14,16,000 Equity Shares aggregating Rs 3.11 Crore.

Apart from the major lab in Kanpur, the major lab in Lucknow, Uttar Pradesh became completely operational w.e.f. April, 2022. The Company is in process to open several diagnostics labs in various parts of the Company.

Parent organization Indian Private
NSE symbol [-]
Founded 2018
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Gian Lifecare Ltd?

Answer Field

Gian Lifecare Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 14.00 as on Sep 02 2025 03:19 PM.

What is the Market Cap of Gian Lifecare Ltd Share?

Answer Field

The market cap of Gian Lifecare Ltd for NSE ₹ 0.00 & for BSE ₹ 14.50 as on Sep 02 2025 03:19 PM.

What is the 52 Week High and Low of Gian Lifecare Ltd?

Answer Field

The 52 Week High and Low of Gian Lifecare Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 24.44 and ₹ 12.06.

What is 1 year return for Gian Lifecare Ltd?

Answer Field

The 1 year returns on the stock has been -32.27%.

What is the P/E Ratio of Gian Lifecare Ltd Share?

Answer Field

As on Sep 02 2025 03:19 PM the price-to-earnings (PE) ratio for Gian Lifecare Ltd share is 5.31.

What is the PB ratio of Gian Lifecare Ltd Share?

Answer Field

As on Sep 02 2025 03:19 PM, the price-to-book (PB) ratio for Gian Lifecare Ltd share is 19.21.

How to Buy Gian Lifecare Ltd Share?

Answer Field

You can trade in Gian Lifecare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Gian Lifecare Ltd Share on Bajaj Broking App?

Answer Field

To buy Gian Lifecare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Gian Lifecare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91